Douglas Hillblom, PharmD

Although there is a persistent need for lower prescription drug costs, this simple concept is complicated by multiple factors.

There has been increasing buzz surrounding health care reform concepts that which seek to address the singular issue of individual health care coverage affordability.

Although nearly every state has some type of rule governing coverage of oncology drugs, the question that continually pops up is whether these rules matter when it comes to formulary inclusion.

New proposed rules for the Medicare Part D drug program could affect the manner in which pharmacy benefit managers administer the program and could impact profitability.

The transition in specialty pharmacy from traditional prescription ordering processes to e-prescribing brings challenges and benefits.